A multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dexamethasone versus dexamethasone alone as initial therapy for newly diagnosed multiple myeloma.

被引：0
|
作者：
Rajkumar, S. V.
Hussein, M.
Catalano, J.
Jedrzejcak, W.
Sirkovich, S.
Olesnyckyj, M.
Yu, Z.
Knight, R.
Zeldis, J. B.
Blade, J.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Frankston Hosp, Frankston, Australia
[4] Med Acad Warsaw, Warsaw, Poland
[5] UAMS, Kiev Inst Oncol, Kiev, Ukraine
[6] Celgene Corp, Summit, NJ USA
[7] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：426S / 426S
页数：1
相关论文
共 50 条
  • [1] A randomized, double-blind, placebo-controlled trial of thalidomide plus dexamethasone versus dexamethasone alone as primary therapy for newly diagnosed multiple myeloma.
    Rajkumar, S. Vincent
    Hussein, Mohamad
    Catalano, John
    Jedrzejcak, Wieslaw
    Sirkovich, Svetlana
    Olesnyckyj, Marta
    Yu, Zhinuan
    Knight, Robert
    Zeldis, Jerry
    Blade, Joan
    BLOOD, 2006, 108 (11) : 238A - 238A
  • [2] Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma
    Rajkumar, S. Vincent
    Rosinol, Laura
    Hussein, Mohamad
    Catalano, John
    Jedrzejczak, Wieslaw
    Lucy, Lela
    Olesnyckyj, Marta
    Yu, Zhinuan
    Knight, Robert
    Zeldis, Jerome B.
    Blade, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2171 - 2177
  • [3] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, Johnny
    O'Ceallaigh, Cathal
    Keane, Colm
    Otridge, Brian W.
    O'Gorman, Peter
    BLOOD, 2006, 108 (11) : 370B - 370B
  • [4] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, J
    Keane, C
    Otridge, BW
    Thornton, P
    O'Gorman, P
    BLOOD, 2005, 106 (11) : 380B - 380B
  • [5] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma
    Gay, Francesca
    Hayman, Suzanne
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russel, Stephen
    Roj, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    BLOOD, 2009, 114 (22) : 1494 - 1495
  • [6] DEXAMETHASONE FOR THE TREATMENT OF DEPRESSION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    ARANA, GW
    SANTOS, AB
    LARAIA, MT
    MCLEODBRYANT, S
    BEALE, MD
    RAMES, LJ
    ROBERTS, JM
    DIAS, JK
    MOLLOY, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (02): : 265 - 267
  • [7] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Meletios A Dimopoulos
    Efstathios Kastritis
    Nature Clinical Practice Oncology, 2008, 5 : 690 - 691
  • [8] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 690 - 691
  • [9] Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
    Rajkumar, SV
    Hayman, S
    Gertz, MA
    Dispenzieri, A
    Lacy, MQ
    Greipp, PR
    Geyer, S
    Iturria, N
    Fonseca, R
    Lust, JA
    Kyle, RA
    Witzig, TE
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) : 4319 - 4323
  • [10] VTD (velcade, thalidomide, dexamethasone) as primary therapy for newly-diagnosed multiple myeloma.
    Alexaman, R
    Wang, LM
    Weber, DM
    Delasalle, KB
    BLOOD, 2004, 104 (11) : 64A - 64A
12345